Artificial Intelligence (AI) in Medical Diagnostics Market to Observe Highest CAGR Growth of 33.9% from 2023-2030: IBM Corporation, Google LLC (Alphabet Inc.), Microsoft Corporation, NVIDIA Corporation

The use of AI technologies and algorithms in the area of medical diagnostics is referred to as artificial intelligence (AI) in the medical diagnostics market. By facilitating more precise and effective medical image processing, data interpretation, and decision-making, AI has the potential to revolutionize medical diagnostics.

In recent years, the market for AI in medical diagnostics has grown significantly. Large medical datasets are becoming more widely available, medical imaging methods are being used more often, and AI algorithms are all contributing to this rise. AI may help medical personnel identify, diagnose, and keep track of a wide range of illnesses and problems, such as cancer, cardiovascular issues, neurological disorders, and more.

Get FREE Sample Report: https://www.delvens.com/get-free-sample/artificial-intelligence-in-medical-diagnostics-market-trends-forecast-till-2030

The global Artificial Intelligence (AI) in Medical Diagnostics Market size is expected to reach USD 12.2 billion and is projected to reach a CAGR of 33.9% from 2023-2030.

Top players covered in Artificial Intelligence (AI) in Medical Diagnostics Market report: IBM Corporation, Google LLC (Alphabet Inc.), Microsoft Corporation, NVIDIA Corporation, General Electric Company (GE Healthcare), Siemens Healthineers AG, Aidoc Medical Ltd., Butterfly Network Inc., Zebra Medical Vision Ltd., AliveCor Inc., Intel Corporation, Digital Diagnostics, Inc., Xilinx, InformAI LLC, HeartFlow, Inc., Enlitic, Inc., Day Zero Diagnostics, Inc., Aidence, Prognos Health, Nanox AI, Viz.ai, Inc., Quibin, Qure.ai, Therapixel, Koninklijke Philips N.V., Lunit. Inc., EchoNous Inc.

Recent Developments

In June 2021, The American College of Cardiology (ACC) and GE Healthcare are working together to create a roadmap for digital technology and artificial intelligence (AI) in cardiology as well as novel approaches for bettering patient outcomes.

In June 2021, By acquiring CardioLabs, AliveCor creates the foundation for the introduction of Advanced Ambulatory Monitoring Services.

The market for artificial intelligence in medical diagnostics includes a number of imaging modalities, including radiology (X-rays, CT scans, MRI), pathology (digital pathology and histology), and other diagnostic methods. AI algorithms are able to analyze medical pictures and offer insights, aid in the early diagnosis of diseases, and aid in the creation of individualized treatment regimens. AI may also help with risk appraisal, prognosis prediction, and therapy response analysis.

The market is also fueled by factors such as the rising burden of chronic illnesses, the desire to improve healthcare outcomes while lowering costs, and the rising need for precise and efficient diagnostic solutions. Additionally, regulatory agencies and healthcare organizations are taking action to develop rules and frameworks to ensure AI's safe and successful incorporation into clinical practice as they see the promise of the technology in diagnostics.

To Grow Your Business Revenue, Make an Inquiry Before Buying at: https://www.delvens.com/Inquire-before-buying/artificial-intelligence-in-medical-diagnostics-market-trends-forecast-till-2030

Scope of the Artificial Intelligence (AI) in Medical Diagnostics Market Report:

The application segment is further segmented into Radiology, pathology, cardiology, oncology, neurology, and others. The application of AI in radiology has gained substantial attention and investment. AI algorithms can analyze medical images and assist radiologists in detecting abnormalities, improving diagnostic accuracy, and enhancing workflow efficiency. This segment is likely to continue growing due to the increasing demand for automated image analysis and the potential to improve patient outcomes.

The technology segment is further fragmented into Machine Learning, Natural Language Processing (NLP), Computer Vision, and Expert Systems. Machine learning techniques, particularly deep learning, have shown tremendous potential in medical diagnostics. Deep learning algorithms can analyze large volumes of medical data and learn patterns and features to aid in diagnosis and decision-making. As the availability of medical data continues to increase and computing power advances, machine learning is expected to drive significant growth in AI in the Medical Diagnostics market.

The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. These regions have been at the forefront of AI adoption in medical diagnostics. Factors such as advanced healthcare infrastructure, significant investments in research and development, and early adoption of AI technologies contribute to the growth of these markets. The presence of leading AI companies, research institutions, and collaborations with healthcare providers further drive the dominance of these regions in the global market.

Regional Analysis

North America to Dominate the Market

The North American region is expected to be the largest region in the Artificial Intelligence (AI) in the Medical Diagnostics market during the forecast period.

The Asia Pacific region, including countries like China, India, and Japan, is also experiencing notable growth due to the increasing healthcare infrastructure, rising awareness about AI, and government initiatives promoting AI adoption in healthcare.

Direct Purchase of the Artificial Intelligence (AI) in Medical Diagnostics Market Research Report at: https://www.delvens.com/checkout/artificial-intelligence-in-medical-diagnostics-market-trends-forecast-till-2030

Contact Us:

UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-8638-5055
SALES@DELVENS.COM
WEBSITE: https://delvens.com/

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

This release was published on openPR.